Literature DB >> 7676454

Effects of ammonium perfluorooctanoate on Leydig cell function: in vitro, in vivo, and ex vivo studies.

L B Biegel1, R C Liu, M E Hurtt, J C Cook.   

Abstract

Ammonium perfluorooctanoate (C8) produced a dose-dependent increase in Leydig cell adenomas in Crl:CD BR (CD) rats fed 0, 30, or 300 ppm for 2 years. Administration of C8 to adult male CD rats, by gavage for 14 days, produced decreased serum and testicular interstitial fluid testosterone levels and increased serum estradiol levels. The C8-mediated decrease in the serum testosterone levels appeared to be due to a lesion at the level of the testis. These endocrine changes may play a role in the C8 induction of Leydig cell tumors. In the present work, C8 was examined for its ability to (1) directly affect Leydig cells in vitro using isolated Leydig cells from untreated rats and ex vivo using Leydig cells isolated from C8-treated rats, (2) affect testicular interstitial fluid hormone levels, and (3) induce aromatase activity. These studies were conducted to investigate the hypothesis that C8 produces an increase in estradiol by inducing cytochrome P450 XIX (aromatase), which converts testosterone to estradiol, and that the elevated estradiol levels ultimately produce Leydig cell hyperplasia and adenoma formation by acting as a mitogen or enhancing growth factor secretion. In the in vivo and ex vivo studies, adult male CD rats were gavaged with either 0 or 25 mg/kg/day C8 for 14 days. In addition to the ad libitum control, a second control group was pair-fed to the 25 mg/kg/day C8 group. In the in vitro and ex vivo studies, Leydig cells were isolated from testes of adult males by collagenase digestion followed by enrichment over Percoll gradients. A dose-dependent decrease in testosterone levels was observed in hCG-stimulated Leydig cells treated in vitro with C8 for 5 hr (IC50 approximately 200 microM). In contrast, ex vivo studies demonstrated an increase in testosterone production in hCG-stimulated Leydig cells from C8-treated rats when compared to Leydig cells isolated from either the ad libitum or pair-fed control rats. The in vitro data demonstrate that C8 directly inhibits testosterone release from Leydig cells, while the ex vivo data demonstrate that this inhibition is reversible.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7676454     DOI: 10.1006/taap.1995.1164

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  31 in total

1.  Perfluoroalkyl and polyfluoroalkyl substances (PFAS) and their effects on the ovary.

Authors:  Ning Ding; Siobán D Harlow; John F Randolph; Rita Loch-Caruso; Sung Kyun Park
Journal:  Hum Reprod Update       Date:  2020-09-01       Impact factor: 15.610

2.  Ammonium perfluorooctanoate may cause testosterone reduction by adversely affecting testis in relation to PPARα.

Authors:  Yufei Li; Doni Hikmat Ramdhan; Hisao Naito; Nozomi Yamagishi; Yuki Ito; Yumi Hayashi; Yukie Yanagiba; Ai Okamura; Hazuki Tamada; Frank J Gonzalez; Tamie Nakajima
Journal:  Toxicol Lett       Date:  2011-06-25       Impact factor: 4.372

3.  Use of high-throughput in vitro toxicity screening data in cancer hazard evaluations by IARC Monograph Working Groups.

Authors:  Weihsueh A Chiu; Kathryn Z Guyton; Matthew T Martin; David M Reif; Ivan Rusyn
Journal:  ALTEX       Date:  2017-07-24       Impact factor: 6.043

4.  Concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) and their associations with human semen quality measurements.

Authors:  James H Raymer; Larry C Michael; William B Studabaker; Geary W Olsen; Carol S Sloan; Timothy Wilcosky; David K Walmer
Journal:  Reprod Toxicol       Date:  2011-06-29       Impact factor: 3.143

Review 5.  Endocrine disruptors and the breast: early life effects and later life disease.

Authors:  Madisa B Macon; Suzanne E Fenton
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-02-17       Impact factor: 2.673

Review 6.  Impact of perfluorochemicals on human health and reproduction: a male's perspective.

Authors:  C Foresta; S Tescari; A Di Nisio
Journal:  J Endocrinol Invest       Date:  2017-11-17       Impact factor: 4.256

7.  Genomic biomarkers of phthalate-induced male reproductive developmental toxicity: a targeted RT-PCR array approach for defining relative potency.

Authors:  Bethany R Hannas; Christy S Lambright; Johnathan Furr; Nicola Evans; Paul M D Foster; Earl L Gray; Vickie S Wilson
Journal:  Toxicol Sci       Date:  2011-11-22       Impact factor: 4.849

8.  Implications of early menopause in women exposed to perfluorocarbons.

Authors:  Sarah S Knox; Timothy Jackson; Beth Javins; Stephanie J Frisbee; Anoop Shankar; Alan M Ducatman
Journal:  J Clin Endocrinol Metab       Date:  2011-03-16       Impact factor: 5.958

9.  Do perfluoroalkyl compounds impair human semen quality?

Authors:  Ulla Nordström Joensen; Rossana Bossi; Henrik Leffers; Allan Astrup Jensen; Niels E Skakkebaek; Niels Jørgensen
Journal:  Environ Health Perspect       Date:  2009-03-02       Impact factor: 9.031

10.  Mortality of employees of a perfluorooctanesulphonyl fluoride manufacturing facility.

Authors:  B H Alexander; G W Olsen; J M Burris; J H Mandel; J S Mandel
Journal:  Occup Environ Med       Date:  2003-10       Impact factor: 4.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.